Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease
- PMID: 23358601
- PMCID: PMC3580269
- DOI: 10.1093/brain/aws327
Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease
Abstract
The factors driving clinical heterogeneity in Alzheimer's disease are not well understood. This study assessed the relationship between amyloid deposition, glucose metabolism and clinical phenotype in Alzheimer's disease, and investigated how these relate to the involvement of functional networks. The study included 17 patients with early-onset Alzheimer's disease (age at onset <65 years), 12 patients with logopenic variant primary progressive aphasia and 13 patients with posterior cortical atrophy [whole Alzheimer's disease group: age = 61.5 years (standard deviation 6.5 years), 55% male]. Thirty healthy control subjects [age = 70.8 (3.3) years, 47% male] were also included. Subjects underwent positron emission tomography with (11)C-labelled Pittsburgh compound B and (18)F-labelled fluorodeoxyglucose. All patients met National Institute on Ageing-Alzheimer's Association criteria for probable Alzheimer's disease and showed evidence of amyloid deposition on (11)C-labelled Pittsburgh compound B positron emission tomography. We hypothesized that hypometabolism patterns would differ across variants, reflecting involvement of specific functional networks, whereas amyloid patterns would be diffuse and similar across variants. We tested these hypotheses using three complimentary approaches: (i) mass-univariate voxel-wise group comparison of (18)F-labelled fluorodeoxyglucose and (11)C-labelled Pittsburgh compound B; (ii) generation of covariance maps across all subjects with Alzheimer's disease from seed regions of interest specifically atrophied in each variant, and comparison of these maps to functional network templates; and (iii) extraction of (11)C-labelled Pittsburgh compound B and (18)F-labelled fluorodeoxyglucose values from functional network templates. Alzheimer's disease clinical groups showed syndrome-specific (18)F-labelled fluorodeoxyglucose patterns, with greater parieto-occipital involvement in posterior cortical atrophy, and asymmetric involvement of left temporoparietal regions in logopenic variant primary progressive aphasia. In contrast, all Alzheimer's disease variants showed diffuse patterns of (11)C-labelled Pittsburgh compound B binding, with posterior cortical atrophy additionally showing elevated uptake in occipital cortex compared with early-onset Alzheimer's disease. The seed region of interest covariance analysis revealed distinct (18)F-labelled fluorodeoxyglucose correlation patterns that greatly overlapped with the right executive-control network for the early-onset Alzheimer's disease region of interest, the left language network for the logopenic variant primary progressive aphasia region of interest, and the higher visual network for the posterior cortical atrophy region of interest. In contrast, (11)C-labelled Pittsburgh compound B covariance maps for each region of interest were diffuse. Finally, (18)F-labelled fluorodeoxyglucose was similarly reduced in all Alzheimer's disease variants in the dorsal and left ventral default mode network, whereas significant differences were found in the right ventral default mode, right executive-control (both lower in early-onset Alzheimer's disease and posterior cortical atrophy than logopenic variant primary progressive aphasia) and higher-order visual network (lower in posterior cortical atrophy than in early-onset Alzheimer's disease and logopenic variant primary progressive aphasia), with a trend towards lower (18)F-labelled fluorodeoxyglucose also found in the left language network in logopenic variant primary progressive aphasia. There were no differences in (11)C-labelled Pittsburgh compound B binding between syndromes in any of the networks. Our data suggest that Alzheimer's disease syndromes are associated with degeneration of specific functional networks, and that fibrillar amyloid-β deposition explains at most a small amount of the clinico-anatomic heterogeneity in Alzheimer's disease.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3580269/bin/aws327f1p.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3580269/bin/aws327f2p.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3580269/bin/aws327f3p.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3580269/bin/aws327f4p.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3580269/bin/aws327f5p.gif)
Similar articles
-
Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.Brain. 2010 Feb;133(Pt 2):512-28. doi: 10.1093/brain/awp326. Epub 2010 Jan 15. Brain. 2010. PMID: 20080878 Free PMC article.
-
Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.Neuroimage Clin. 2014 Mar 19;4:508-16. doi: 10.1016/j.nicl.2014.03.005. eCollection 2014. Neuroimage Clin. 2014. PMID: 24818077 Free PMC article.
-
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.Brain. 2016 May;139(Pt 5):1551-67. doi: 10.1093/brain/aww027. Epub 2016 Mar 8. Brain. 2016. PMID: 26962052 Free PMC article.
-
Breakdown of specific functional brain networks in clinical variants of Alzheimer's disease.Ageing Res Rev. 2021 Dec;72:101482. doi: 10.1016/j.arr.2021.101482. Epub 2021 Oct 2. Ageing Res Rev. 2021. PMID: 34606986 Review.
-
Amyloid imaging in atypical presentations of Alzheimer's disease.Curr Neurol Neurosci Rep. 2013 Dec;13(12):412. doi: 10.1007/s11910-013-0412-x. Curr Neurol Neurosci Rep. 2013. PMID: 24136459 Free PMC article. Review.
Cited by
-
Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's disease.Brain Commun. 2024 May 3;6(3):fcae159. doi: 10.1093/braincomms/fcae159. eCollection 2024. Brain Commun. 2024. PMID: 38784820 Free PMC article.
-
Potential Modifying Effect of the APOEε4 Allele on Age of Onset and Clinical Manifestations in Patients with Early-Onset Alzheimer's Disease with and without a Pathogenic Variant in PSEN1 in a Sample of the Mexican Population.Int J Mol Sci. 2023 Oct 28;24(21):15687. doi: 10.3390/ijms242115687. Int J Mol Sci. 2023. PMID: 37958671 Free PMC article.
-
Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease.Brain Commun. 2023 Oct 18;5(6):fcad280. doi: 10.1093/braincomms/fcad280. eCollection 2023. Brain Commun. 2023. PMID: 37942088 Free PMC article.
-
Longitudinal associations between β-amyloid and cortical thickness in mild cognitive impairment.Brain Commun. 2023 Jul 4;5(4):fcad192. doi: 10.1093/braincomms/fcad192. eCollection 2023. Brain Commun. 2023. PMID: 37483530 Free PMC article.
-
Network anatomy in logopenic variant of primary progressive aphasia.Hum Brain Mapp. 2023 Aug 1;44(11):4390-4406. doi: 10.1002/hbm.26388. Epub 2023 Jun 12. Hum Brain Mapp. 2023. PMID: 37306089 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous